Salventis
Innovative Care  ·  Trusted Quality
🔔 Salventis Pharma is ready to serve you — anytime, any day. Hospital procurement, partnerships & enquiries welcome. Click Here →
📞 +92 300 8255019
☎ +92 51 6108078
✉ info@salventispharma.com
Prescription medicines · for healthcare professionals
🇵🇰 Islamabad, Pakistan
Home Vision & Mission About Us Roadmap Leadership Medicines Careers News Contact Enquire Now →
Islamabad · Pakistan

Specialist Medicines That
Protect & Heal

Innovative Care. Trusted Quality.

We exist to make life-saving specialty medicines accessible — reliably, affordably, with the clinical integrity Pakistan's patients deserve.

4
Therapeutic Areas
7
Specialty Brands
50+
Years Leadership
💊Prescription-only medicines
🧬Anti-Infectives · Oncology & Bone Health · Urology · Gastroenterology
🏭Manufactured by licensed partners in Pakistan
🇵🇰Islamabad, Pakistan
🩺Information for healthcare professionals
🔭Pipeline: oncology & contrast media
💊Prescription-only medicines
🧬Anti-Infectives · Oncology & Bone Health · Urology · Gastroenterology
🏭Manufactured by licensed partners in Pakistan
🇵🇰Islamabad, Pakistan
🩺Information for healthcare professionals
🔭Pipeline: oncology & contrast media
Our Purpose

Vision & Mission

Science-driven. Patient-centred. Built to make life-saving medicines accessible across Pakistan.

✦ Our Vision

To be Pakistan's most trusted partner in bringing life-saving medicines to every patient.

Salventis Pharma aspires to be the definitive bridge between global pharmaceutical innovation and Pakistan's healthcare system — recognised by clinicians, institutions, and patients as the standard of excellence in specialty pharmaceutical distribution. By 2030, Salventis will have established itself as the partner of choice for international pharmaceutical principals seeking credible, compliant, and commercially capable representation in Pakistan.

✦ Our Mission

To introduce high-quality, innovative therapies that meaningfully improve patient outcomes.

Sourcing with integrity — partnering exclusively with reputable manufacturers who share our commitment to quality and compliance.
Distributing with precision — maintaining product integrity, regulatory compliance and quality standards at every step.
Engaging with expertise — leveraging deep therapeutic knowledge to deliver meaningful clinical value to healthcare professionals.
What We Stand For

Core Values

01🔬
Scientific Integrity

Every product decision grounded in clinical evidence. Science-driven commercialisation — never compromising quality for commercial gain.

02🤝
Patient-Centred Purpose

We measure success in patient outcomes — every therapy represents a life touched, a condition managed, a family supported.

03🏛️
Regulatory Excellence

Full DRAP compliance and international regulatory expertise are foundational — not optional. We navigate complex frameworks to ensure safe, reliable delivery.

04🌍
Global Partnerships

Strategic alliances with reputable international manufacturers — bringing monoclonal antibodies and specialty diagnostics into the Pakistani market.

05⚙️
Operational Excellence

Cold-chain integrity, on-time delivery, and supply reliability are operational standards — not aspirations. We deliver what we promise.

06💡
Long-Term Value Creation

Building lasting value for healthcare institutions, principal partners, distribution networks, and the patients whose lives depend on innovative therapies.

Salventis pharmaceutical laboratory
We Are Salventis
Our Mission In Action

Doing Now What Patients
Need Next

From Islamabad to every hospital and clinic across Pakistan — our medicines are making a measurable difference in patient lives, one vial at a time.

Hospital care
01
🏥
Hospital-Grade Access

We bring carbapenem antibiotics, bisphosphonates, and contrast agents to hospitals, ICUs, and oncology centres that need them most — at prices that enable institutional procurement.

Learn about Critical Care →
Oncology research
02
🧬
Oncology for Pakistan

Zolegen® and Pregolix® support oncologists, urologists and bone specialists — from skeletal protection in advanced cancer to oral androgen deprivation in prostate cancer.

Learn about Oncology →
Strategic partnership
03
🤝
Strategic Partnerships

Actively seeking international collaborations in oncology, radiology, and specialty therapeutics — including monoclonal antibodies — to expand Pakistan's access to cutting-edge pharmaceutical innovations.

Explore Partnerships →
Our Growth Roadmap

Expanding Therapeutic Horizons

From four therapeutic areas today to a broader specialty portfolio — here is our path forward.

💉
Active now
Anti-Infectives

Merovion® (meropenem 500 mg & 1 g) and Tigradox® (tigecycline 50 mg) for hospital and critical care.

● Live
🧬
Active now
Oncology, Urology & Gastroenterology

Zolegen®, Pregolix®, Tamstone-D®, Tamstone® and Acosky® for specialist care.

● Live
📡
Target Q4 2026
Radiology & Oncology Pipeline

Iohexol and gadobutrol contrast media, and nab-paclitaxel. Regulatory status to be confirmed.

◐ Pipeline
❤️
2027
Cardiology

A cardiovascular specialty portfolio is in planning.

○ Planned
Founding Leadership

The Experience Behind
Salventis Pharma

👤
Zillur Rahman Qureshi
Founder & Chief Executive Officer
Salventis Pharma (SMC-Private) Limited
🎓 MBA — Marketing
📅 50+ Years Experience
🌍 Multinational Leadership

"A firm believer in ethical, science-driven commercialisation — with a consistent focus on innovation, operational excellence, and long-term value creation."

Zillur Rahman Qureshi brings over 50 years of distinguished pharmaceutical leadership across multinational and leading local organisations in Pakistan and internationally. Holding an MBA in Marketing complemented by extensive executive training in strategic planning, portfolio management, and international business.

His executive career spans C-suite and board-level roles — including Managing Director, Chief Operating Officer, and Director of Marketing — with landmark contributions to Sanofi Aventis and Boehringer Mannheim, as well as leading pharmaceutical groups across Pakistan.

Therapeutic Expertise
Oncology Cardiology Immunology Radiology Monoclonal Antibodies Specialty Diagnostics
🏢Sanofi Aventis— Senior Executive Leadership
🏢Boehringer Mannheim— International Pharma Leadership
🏢Leading Local Pharma Groups— MD, COO & Director Marketing roles
⭐Salventis Pharma (SMC-Private) Limited— Founder & CEO · Islamabad (Current)
Our Portfolio
Discover Our Medicines

Seven prescription brands across four therapeutic areas. Select a product for its scientific and prescribing information.

Anti-InfectivesMerovion® · Tigradox® Oncology & Bone HealthZolegen® · Pregolix® UrologyTamstone-D® · Tamstone® GastroenterologyAcosky®
Merovion® pack
Anti-Infectives
Merovion®
Meropenem USP
500 mg · 1 g vial
Product information →
Tigradox® pack
Anti-Infectives
Tigradox®
Tigecycline
50 mg vial
Product information →
Zolegen® pack
Oncology & Bone Health
Zolegen®
Zoledronic Acid
5 mg/100 mL · 4 mg/5 mL
Product information →
Pregolix® pack
Oncology · Urology
Pregolix®
Relugolix
120 mg tablets
Product information →
Tamstone-D® pack
Urology
Tamstone-D®
Tamsulosin + Dutasteride
0.4 mg + 0.5 mg capsules
Product information →
Tamstone® pack
Urology
Tamstone®
Tamsulosin HCl
0.4 mg capsules
Product information →
Acosky® pack
Gastroenterology
Acosky®
Acotiamide HCl Hydrate
100 mg tablets
Product information →
All medicines
Browse the full portfolio by therapeutic area, and see our pipeline in oncology and contrast media.
Open the medicines directory →

Product information is intended for healthcare professionals in Pakistan. All products are prescription-only medicines.

🏢
About Salventis

Our story, our mission, and the team behind Pakistan's forward-looking specialty pharma distributor.

Learn More →
💊
Solutions

Hospital procurement, distribution partnerships, and HCP engagement programmes across Pakistan.

Explore →
🔬
Innovation

Actively seeking partnerships in oncology, radiology, and specialty therapeutics including monoclonal antibodies.

Partner With Us →
📊
Investors & Media

Information for investors, media enquiries, and strategic collaborators interested in Salventis Pharma.

Get In Touch →
🌟 Purpose-Driven Work
🚀 Fast-Growing Company
🏥 Healthcare Impact
📍 Islamabad, Pakistan
👥
Join Our Team

Be part of a team changing healthcare access in Pakistan — one life-saving medicine at a time.

Join Our Team

Build Your Career in Specialty Pharma

At Salventis Pharma, we are building Pakistan's most trusted specialty pharmaceutical distributor. We are looking for passionate, science-driven professionals who share our commitment to improving patient outcomes and bringing innovative therapies to healthcare professionals across the country.

🎯
Purpose-Driven Mission
Every role contributes directly to patient access and healthcare outcomes
📈
Growth Opportunity
Be part of a fast-growing specialty pharma company from its foundation
🧬
Scientific Environment
Work with oncology, critical care, and specialty therapeutic portfolios
🤝
Expert Leadership
Learn from 45+ years of multinational pharmaceutical experience
Explore Opportunities →
🤝

Seeking Strategic Partnerships

Salventis Pharma is actively seeking collaborations with international and local pharmaceutical principals — particularly in oncology, radiology, and specialty therapeutics, including monoclonal antibodies and diagnostic imaging products.

Industry News

Pharmaceutical Newsroom

Curated pharmaceutical and healthcare news relevant to our therapeutic areas. Click any article to read on the original source — updated regularly.

💊 Biopharma Live
📰 BioPharma Dive
Latest Drug Approvals & Pharmaceutical Industry News

Breaking news on FDA approvals, clinical trial results, oncology advances, and global biopharma industry developments — daily updates.

🧬 Oncology & R&D
📰 Pharmaphorum
2026 Biopharma Trends: AI, Oncology & Cardiometabolic Advances

AI-driven drug development, advanced therapeutics, and cardiometabolic medicines dominate 2026 pipelines. Oncology and precision medicine at the forefront.

🔬 Antibiotics
📰 MDPI Antibiotics
Tigecycline & Meropenem: New 2026 Clinical Pharmacokinetic Data

New pharmacokinetic data on tigecycline and meropenem in ICU settings. Pakistan's AMR agenda highlights growing demand for reserve IV antibiotics.

More sources: BioPharma Dive ↗ NEJM ↗ The Lancet ↗ Pharmaphorum ↗ WHO Antibiotics ↗
Reach Us

Let's Start a Conversation

Hospital procurement, distribution partnerships, HCP enquiries, or investment discussions — we're ready to help.

Contact Information
📍
Head Office
Apt. A-3, 3rd Floor, Plaza No. 8
Civic Centre, Bahria Town Phase 4
Islamabad, Pakistan
📞
☎️
✉️
General Enquiries
Theme